Role of distinct acyl-CoA ceramides in metabolic disease

Jens Brüning - Max-Planck-Institut

November 5th, 2015
Main Auditorium
Host: Roger Sandhof

Biosketch Jens Bruening

In mid-February 2012, the endocrinologist and geneticist Jens C. Brüning took up the position of Director of the Max Planck Institute for Metabolism Research. He gained his doctorate (1993) at the University of Cologne. Here, he was awarded the venia legendi for Internal Medicine/Endocrinology (2002). As a researcher he is interested in the (neuronal) regulation of energy and glucose metabolism in connection with age-associated (e.g., type 2 diabetes) and neurodegenerative diseases (e.g., Morbus Alzheimer, Morbus Parkinson). In 2013 he received the American Diabetes Association’s Outstanding Scientific Achievement Award. In 2009, he was honoured with the “Ernst Jung-Preis für Medizin”; in 2008, he received the “Minkowski-Price” of the European Association for the Study of Diabetes preceded by the “Gottfried Wilhelm Leibniz-Preis” of the German Research Association in 2007. The “Wilhelm Vaillant-Preis” as well as the “Ferdinand Bertram-Preis” of the German Diabetes Association were committed to him in 2005. Already in 2001 he was received the distinction “Ernst und Berta Scharrer-Preis” of the German Association for Endocrinology.

to top
powered by webEdition CMS